Methylnaltrexone

Molecular mass: 356.441 g/mol  PubChem compound: 16089915

Therapeutic indications

Methylnaltrexone is indicated for:

Opioid-induced constipation

Population group: only adults (18 years old or older)

Methylnaltrexone is indicated for the treatment of opioid-induced constipation when response to laxative therapy has not been sufficient in adult patients, aged 18 years and older.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Methylnaltrexone is contraindicated in the following cases:

Gastrointestinal obstruction or perforation

at least one of
Gastrointestinal obstruction
Gastrointestinal perforation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.